Scarica l'app Stockscreener
3.20
3.51%
-0.1165
Dopo l'orario di chiusura:
3.20
Precedente Chiudi:
$3.3165
Aprire:
$3.1868
Volume 24 ore:
18,592
Relative Volume:
1.45
Capitalizzazione di mercato:
$44.90M
Reddito:
-
Utile/perdita netta:
$-10.54M
Rapporto P/E:
-1.4153
EPS:
-2.261
Flusso di cassa netto:
$-7.21M
1 W Prestazione:
+0.79%
1M Prestazione:
-14.66%
6M Prestazione:
-17.10%
1 anno Prestazione:
+4.92%
Intervallo 1D:
$3.1648
$3.40
Intervallo di 1 settimana:
$2.9464
$3.40
Portata 52W:
$2.0101
$11.44
Intensity Therapeutics Inc Stock (INTS) Company Profile
Nome
Intensity Therapeutics Inc
Settore
Industria
Telefono
203-221-7381
Indirizzo
61 WILTON ROAD, 3RD FLOOR, WESTPORT
Intensity Therapeutics Inc Borsa (INTS) Ultime notizie
INTSIntensity Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan
This Alumis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Announce the First Patient Dosed in the Randomized, Presurgical Triple Negative Breast Cancer Phase 2 Clinical Trial (INVINCIBLE-4 / SAKK 66/22) - PR Newswire
Balancing Decisions Around Breast Cancer Treatment and Fertility, Breastfeeding - Curetoday.com
Intensity Therapeutics grants stock options to top executives By Investing.com - Investing.com South Africa
Intensity Therapeutics grants stock options to top executives - Investing.com
Biliary Tumor Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - Barchart
SONIRE’s HIFU Therapy System Designated as Breakthrough Device by FDA - BioSpace
SONIRE's HIFU Therapy System Designated as Breakthrough Device by FDA - The Manila Times
Cholangiocarcinoma Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - The Globe and Mail
Thoracic Re-irradiation With Definitive External Beam Radiation Therapy Using Intensity Modulated Radiation Therapy: A Case Report - Cureus
There is Nothing Pink About Breast Cancer - Curetoday.com
Head and Neck Cancer Therapeutics Market Overview: Breakthrough Treatments, Technological Innovations, and ... - WhaTech
An Analysis of Ideaya Biosciences Inc (IDYA)’s Potential Price Growth - Knox Daily
Weekly Investment Analysts’ Ratings Changes for Incyte (INCY) - Defense World
Inogen: Upside Seems Limited After Big Move Up (NASDAQ:INGN) - Seeking Alpha
InvenTrust Properties (NYSE:IVT) Sees Strong Trading Volume - Defense World
Skandinaviska Enskilda Banken AB publ Increases Position in Itron, Inc. (NASDAQ:ITRI) - Defense World
Ideaya Biosciences price target lowered to $52 from $54 at Wedbush - TipRanks
Hoosier Hysterics Podcast: Sisley commits, plus IUWBBs Shay Ciezki and Karoline Striplin - 247Sports
Ideaya Biosciences should be bought on weakness, says Citi - TipRanks
Intapp, Inc. (NASDAQ:INTA) Shares Sold by Hood River Capital Management LLC - MarketBeat
(TIL) Long Term Investment Analysis - Stock Traders Daily
Itim Group PLC Announces Strong Mid-Year Financials - TipRanks
ITT Educational Services (OTCMKTS:ESINQ) Stock Price Passes Above Two Hundred Day Moving Average of $0.00 - Defense World
InvenTrust Properties Corp. Announces Upsizing and Pricing of Common Stock Offering - StockTitan
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Intense Technologies Limited's (NSE:INTENTECH) CEO For Now - Simply Wall St
US FDA Closes Out Problem Applications One Federal Register Notice At A Time - Pink Sheet
Ideaya Biosciences price target lowered to $66 from $68 at Stifel - TipRanks
BTIG maintains $62 target on Ideaya Biosciences stock - Investing.com
From Statins to PSCK9 Inhibitors: Choosing the Right Therapy for Cholesterol - Pharmacy Times
Intercontinental Exchange, Inc. (NYSE:ICE) Shares Sold by Interval Partners LP - Defense World
ILLIT Comeback 'I'll Like You' Mini-Album: Release Date, Tracklist - J-14
Integra Lifesciences Holdings Corp (IART) Becoming More Attractive for Investors - Knox Daily
Itau Unibanco Holding S.A. Acquires New Position in Incyte Co. (NASDAQ:INCY) - Defense World
ILLIT Announce First Comeback With Upcoming Mini-Album ‘I’LL LIKE YOU’ - Billboard Philippines
ILLIT announces 2nd mini-album I'LL LIKE YOU, set for October 21 release, marking comeback 7 months after debut - PINKVILLA
ILLIT flaunts 'candid charm' in upcoming EP 'I'll Like You' - ABS-CBN News
ILLIT to Make a Comeback After 7 Months with New Album in October - KBIZoom
Itau Unibanco Holding S.A. Purchases New Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) - Defense World
ILLIT announces the date for their first comeback - Music Mundial News
Update: ILLIT Shares New Brand Film For Upcoming “I’LL LIKE YOU” Comeback - soompi
Pacer Advisors Inc. Acquires 1,175,857 Shares of Titan International, Inc. (NYSE:TWI) - Defense World
ITM Power (OTCMKTS:ITMPF) Stock Price Down 4.1% - Defense World
Titan Machinery Inc. (NASDAQ:TITN) Given Average Rating of "Hold" by Brokerages - MarketBeat
ITM Power (OTCMKTS:ITMPF) Trading Down 4.1% - MarketBeat
Thrivent Financial for Lutherans Sells 30,265 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) - Defense World
Thrivent Financial for Lutherans Buys 109,795 Shares of Intercontinental Exchange, Inc. (NYSE:ICE) - Defense World
Pacer Advisors Inc. Buys 2,676,851 Shares of Incyte Co. (NASDAQ:INCY) - Defense World
First Eagle Investment Management LLC Raises Stake in Iteris, Inc. (NASDAQ:ITI) - Defense World
Intensity Therapeutics shares rise on Buy rating from Brookline Capital - Investing.com
Intensity Therapeutics Inc Azioni (INTS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.11%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):